Orange County NC Website
Browse       Search
DocuSign Envelope ID:79C5D167-B6CA-4E59-B4AC-AA38CC1 B20BD <br /> EC 11 : Hepatitis B Vaccine and Post-Exposure Evaluation and Follow Up (Continued): <br /> • Post-Exposure Evaluation and Follow-Up: <br /> o All exposure incidents shall be reported, investigated, and documented. <br /> When the employee incurs an exposure incident, it shall be reported to the <br /> Infection Control Officer for investigation. <br /> o Following a report of an exposure incident, the exposed employee shall <br /> immediately receive a confidential medical evaluation and follow-up, <br /> including at least the following elements: <br /> ■ Documentation of the route of exposure, and the circumstances <br /> under which the exposure incident occurred; <br /> ■ Identification and documentation of the source individual, unless it <br /> can be established that identification is infeasible or prohibited by <br /> state of local law. <br /> ■ The source individual's blood shall be tested as soon as feasible <br /> and after consent is obtained in order to determine HBV and HIV <br /> infectivity. If consent is not obtained, the Infection Control Officer <br /> shall establish that legally required consent cannot be obtained. <br /> When law does not require the source individual's consent, the <br /> source individual's blood, if available, shall be tested and the results <br /> documented. <br /> ■ When the source individual is already known to be infected with <br /> HBV or HIV, testing for the source individual's known HBV or HIV <br /> status need not be repeated. <br /> ■ Results of the source individual's testing shall be made available to <br /> the exposed employee, and the employee shall be informed of <br /> applicable laws and regulations concerning disclosure of the <br /> identity and infectious status of the source individual. <br /> ■ Collection and testing of blood for HBV and HIV serological status <br /> will comply with the following: <br /> • The exposed employee's blood shall be collected as soon as <br /> feasible and tested after consent is obtained; <br /> • The employee will be offered the option of having their blood <br /> collected for testing of the employee's HIV/HBV serological <br /> status. The blood sample will be preserved for up to 90 days <br /> to allow the employee to decide if the blood should be tested <br /> for HIV serological status. <br /> ■ Each employee who incurs an exposure incident will be offered <br /> post-exposure evaluation and follow-up in accordance with the <br /> OSHA standard. All post exposure follow-up will be performed by <br /> the County/Entity Health Department or other identified healthcare <br /> provider. <br /> Revised July,2018 <br />